Target intelligence / Profile preview

Bacterial cell envelope and membrane

Molecular classification
Other, Cellular structure
01

Overview

The bacterial cell envelope is a complex, multi-layered structure that serves as the primary interface between a bacterium and its environment, providing structural integrity and protection against osmotic pressure. It typically comprises the inner cytoplasmic membrane and a peptidoglycan-based cell wall, with Gram-negative bacteria possessing an additional outer membrane containing lipopolysaccharides (Silhavy et al., 2010). This structure is a fundamental therapeutic target because many of its components, such as peptidoglycan, are unique to bacteria, allowing for high selective toxicity (Kohanski et al., 2010). Antibiotics like beta-lactams and glycopeptides target the synthesis of the cell wall, while polymyxins and lipopeptides directly disrupt the integrity of the lipid membranes (Zheng et al., 2017). Beyond its role as a target, the envelope acts as a formidable barrier to drug penetration, and its modification is a central mechanism in the development of antibiotic resistance (Delcour, 2009). Consequently, understanding the envelope's composition is critical for the design of novel antimicrobial agents capable of overcoming protective barriers.

Other names
Bacterial cell wallCytoplasmic membraneOuter membranePeptidoglycan layerCell envelope
02

Mechanism of action

Inhibition of peptidoglycan biosynthesis through the targeting of transpeptidases and transglycosylases, disruption of cytoplasmic membrane potential and permeability, and binding to lipopolysaccharides or lipid II to compromise the structural integrity of the cell boundary.

03

Biological functions

Structural integrityPermeability barrierOsmotic protectionMolecular transportCell divisionSignal transduction
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityOtotoxicityDisruption of commensal microbiotaDevelopment of antimicrobial resistanceHypersensitivity reactions
06

Interacting drugs

Amoxicillin

7 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)ProcalcitoninC-reactive proteinBacterial DNA load

Beyond the preview

Go deeper on Bacterial cell envelope and membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell envelope and membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call